Status:
COMPLETED
The Effects of Sphenopalatine Ganglion Acupuncture in Patients With Seasonal Allergic Rhinitis
Lead Sponsor:
Beijing Tongren Hospital
Conditions:
Patients
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Sphenopalatine ganglion (SPG)-acupuncture has been shown to exhibit distinct effects in treatment of nasal inflammatory disease. Investigators aimed to assess the effects of SPG acupuncture in patient...
Eligibility Criteria
Inclusion
- patients with a history of at least 2 years of seasonal allergic rhinitis
- no smoking
- without history of nasal polyps, nasal septum deviation and history of nose surgery) or lung disease (asthma, chronic obstructive pulmonary disease and fibrosis)
- free of upper and lower respiratory tract infections for at least 4 weeks before beginning the study.
Exclusion
- had received acupuncture within the last four weeks before the study
- history of diabetes mellitus, autonomic neuropathy, coronary heart disease or hypertension.
Key Trial Info
Start Date :
January 16 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2017
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03282630
Start Date
January 16 2016
End Date
February 20 2017
Last Update
September 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tongren Hospital
Beijing, Beijing Municipality, China, 100730